The software company, founded in 2018, specializes in artificial intelligence-based diagnostics tests and robotic technologies for patients and healthcare providers and won the 2019 and 2020 fastMRI challenge, according to an Aug. 19 AIRS Medical news release.
Q Capital Partners and Hanwha Life joined the funding round, as well as Klim Ventures, which also participated in its series A funding.
“We believe we can transform the healthcare ecosystem by solving the current dependency on analog machines by replacing them with data-driven medicine,” CEO of AIRS Medical Hye-seong Lee said. “Through the series B funding we’ve secured, we will be taking our innovative diagnostic solutions to the global market.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
